COVID-19: VACCINE WATCH

Government official: Coronavirus vaccine trial starts Monday

Mar 16, 2020, 5:16 AM
A gun store customer that gave his name only at John waits in line, Sunday, March 15, 2020, in Burb...
A gun store customer that gave his name only at John waits in line, Sunday, March 15, 2020, in Burbank, Calif. As consumers are buying all kinds of goods in large quantities amid coronavirus concerns, putting pressure on inventories, John stated that he was there to buy ammunition because most other stores were out and he wanted to stock up. (AP Photo/Mark J. Terrill)
(AP Photo/Mark J. Terrill)

WASHINGTON (AP) — The first participant in a clinical trial for a vaccine to protect against the new coronavirus will receive an experimental dose on Monday, according to a government official.

The National Institutes of Health is funding the trial, which is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle. The official who disclosed plans for the first participant spoke on condition of anonymity because the move has not been publicly announced.

Public health officials say it will take a year to 18 months to fully validate any potential vaccine.

Testing will begin with 45 young, healthy volunteers with different doses of shots co-developed by NIH and Moderna Inc. There’s no chance participants could get infected from the shots, because they don’t contain the virus itself. The goal is purely to check that the vaccines show no worrisome side effects, setting the stage for larger tests.

Dozens of research groups around the world are racing to create a vaccine as COVID-19 cases continue to grow. Importantly, they’re pursuing different types of vaccines — shots developed from new technologies that not only are faster to produce than traditional inoculations but might prove more potent. Some researchers even aim for temporary vaccines, such as shots that might guard people’s health a month or two at a time while longer-lasting protection is developed.

Also in the works: Inovio Pharmaceuticals aims to begin safety tests of its vaccine candidate next month in a few dozen volunteers at the University of Pennsylvania and a testing center in Kansas City, Missouri, followed by a similar study in China and South Korea.

Even if initial safety tests go well, “you’re talking about a year to a year and a half” before any vaccine could be ready for widespread use, according to Dr. Anthony Fauci, director of NIH’s National Institute of Allergy and Infectious Diseases.

That still would be a record-setting pace. But manufacturers know the wait — required because it takes additional studies of thousands of people to tell if a vaccine truly protects and does no harm — is hard for a frightened public.

President Donald Trump has been pushing for swift action on a vaccine, saying in recent days that the work is “moving along very quickly” and he hopes to see a vaccine “relatively soon.”

Today, there are no proven treatments. In China, scientists have been testing a combination of HIV drugs against the new coronavirus, as well as an experimental drug named remdesivir that was in development to fight Ebola. In the U.S., the University of Nebraska Medical Center also began testing remdesivir in some Americans who were found to have COVID-19 after being evacuated from a cruise ship in Japan.

For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The worldwide outbreak has sickened more than 156,000 people and left more than 5,800 dead. The death toll in the United States is more than 50, while infections neared 3,000 across 49 states and the District of Columbia.

The vast majority of people recover. According to the World Health Organization, people with mild illness recover in about two weeks, while those with more severe illness may take three weeks to six weeks to recover.

___

The Associated Press receives support for health and science coverage from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Today’s Top Stories

COVID-19: Vaccine Watch

A sign reading "immunizations" hangs over a desk. COVID-19 vaccines Utah...
Samantha Herrera

Where to find a COVID-19 vaccine provider for children 5 and under in Utah

COVID-19 vaccines are now available for children as young as 6 months old, but where can you find a vaccine provider for your child in Utah?
4 days ago
A child is comforted after getting his COVID-19 vaccine....
Samantha Herrera

More COVID-19 vaccines ordered in Utah for children as young as 6 months

32,000 doses of COVID-19 vaccines for children 6 months and older have been ordered by the Utah Department of Health and Human Services.
5 days ago
This combination of 2022 and 2020 file  photos shows logos for the U.S. Centers for Disease Control...
LAURAN NEERGAARD AP Medical Writer

Marathon US hearings to decide fate of COVID shots for tots

On Wednesday, both Moderna and Pfizer will argue their case. Each company aims to offer a different dose and number of shots.
17 days ago
FILE - A vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. ...
LOLITA C. BALDOR Associated Press

New vaccine may be option for troops with religious concerns

At least 175 active duty and reserve service members have received the Novavax vaccine. Some have traveled overseas at their own expense to get it.
18 days ago
utah student achievement COVID-19...
Simone Seikaly

Utah student performance knocked down during COVID-19 restrictions

A review of multiple Utah student performance exams found "significant impacts" in mathematics achievement across grades.
25 days ago
COVID-19 vaccine...
KEVIN McGILL

Opponents of federal vaccine mandate seek rehearing

Mr. Biden issued an order Sept. 9 that more than 3.5 million federal executive branch workers undergo vaccination, with no option to get regularly tested.
1 month ago

Sponsored Articles

Tax Harassment...
Jordan Wilcox

The best strategies for dealing with IRS tax harassment | You have options!

Learn how to deal with IRS tax harassment. This guide will teach you how to stop IRS phone calls and letters, and how to handle an IRS audit.
spend a day at Bear Lake...
Bear Lake Convention and Visitors Bureau

You’ll love spending the day at Bear Lake | How to spend a day at Bear Lake

Bear Lake is a place that needs to be experienced. Spend a day at Bear Lake.
Curb Appeal...
Price's Guaranteed Doors

How to have the best of both worlds for your house | Home security and curb appeal

Protect your home and improve its curb appeal with the latest security solutions like beautiful garage doors and increased security systems.
Prescription opioids can be disposed of during National Prescription Take Back Day...
Know Your Script

Prescription opioid misuse | How to protect your family from the opioid epidemic

Studies have shown that prescription opioid misuse has increased since COVID-19. So what do you need to know about these opioids?
Follow @ikeyospe...

Tax Tuesday: The Most Common Mistakes People Make When Filing Their Taxes

Fortunately, for most average earners, they will not end up owing overpayments received for the Child Tax Credit in 2021.
Follow @ikeyospe...

Tax Tuesday: How will last year’s child tax credits affect you?

Fortunately, for most average earners, they will not end up owing overpayments received for the Child Tax Credit in 2021.
Government official: Coronavirus vaccine trial starts Monday